Management of cardiac implantable electronic device infections: the challenges of understanding the scope of the problem and its associated mortality

References

• Hayes DL, Furman S. Cardiac pacing: how it started, where we are, where we are going. Pacing Clin. Electrophysiol. 27(5), 693–704 (2004).
   Google Scholar
• Wilkoff BL, Auricchio A, Brugada J et al.; Heart Rhythm Society; European Heart Rhythm Association; American College of Cardiology; American Heart Association; European Society of Cardiology; Heart Failure Association of ESC; Heart Failure Society of America. HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. Heart Rhythm 5(6), 907–925 (2008).
   PubMed Web of Science ®Google Scholar
• Goldberger Z, Lampert R. Implantable cardioverter–defibrillators: expanding indications and technologies. JAMA 295(7), 809–818 (2006).
   Google Scholar
• Baddour LM, Epstein AE, Erickson CC et al.; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; Council on Cardiovascular Disease in Young; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Nursing; Council on Clinical Cardiology; Interdisciplinary Council on Quality of Care; American Heart Association. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation 121(3), 458–477 (2010).
   PubMed Web of Science ®Google Scholar
• Epstein AE, DiMarco JP, Ellenbogen KA et al.; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 117(21), e350–e408 (2008).
   PubMed Web of Science ®Google Scholar
• Greenspon AJ, Patel JD, Lau E et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter–defibrillators in the United States 1993 to 2008. J. Am. Coll. Cardiol. 58(10), 1001–1006 (2011).
   PubMed Web of Science ®Google Scholar
• Mond HG, Irwin M, Morillo C, Ector H. The world survey of cardiac pacing and cardioverter defibrillators: calendar year 2001. Pacing Clin. Electrophysiol. 27(7), 955–964 (2004).
   PubMedGoogle Scholar
• Uslan DZ, Tleyjeh IM, Baddour LM et al. Temporal trends in permanent pacemaker implantation: a population-based study. Am. Heart J. 155(5), 896–903 (2008).
   PubMed Web of Science ®Google Scholar
• Tarakji KG, Chan EJ, Cantillon DJ et al. Cardiac implantable electronic device infections: presentation, management, and patient outcomes. Heart Rhythm 7(8), 1043–1047 (2010).
   PubMed Web of Science ®Google Scholar
• Baddour LM, Bettmann MA, Bolger AF et al.; AHA. Nonvalvular cardiovascular device-related infections. Circulation 108(16), 2015–2031 (2003).
   PubMed Web of Science ®Google Scholar
• Mela T, McGovern BA, Garan H et al. Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter- defibrillator implants. Am. J. Cardiol. 88(7), 750–753 (2001).
   PubMed Web of Science ®Google Scholar
• Lai KK, Fontecchio SA. Infections associated with implantable cardioverter defibrillators placed transvenously and via thoracotomies: epidemiology, infection control, and management. Clin. Infect. Dis. 27(2), 265–269 (1998).
   PubMed Web of Science ®Google Scholar
• Smith PN, Vidaillet HJ, Hayes JJ et al. Infections with nonthoracotomy implantable cardioverter defibrillators: can these be prevented? Endotak Lead Clinical Investigators. Pacing Clin. Electrophysiol. 21(1 Pt 1), 42–55 (1998).
   PubMed Web of Science ®Google Scholar
• Frame R, Brodman RF, Furman S, Andrews CA, Gross JN. Surgical removal of infected transvenous pacemaker leads. Pacing Clin. Electrophysiol. 16(12), 2343–2348 (1993).
   PubMedGoogle Scholar
• Hill PE. Complications of permanent transvenous cardiac pacing: a 14-year review of all transvenous pacemakers inserted at one community hospital. Pacing Clin. Electrophysiol. 10(3 Pt 1), 564–570 (1987).
   Google Scholar
• Aggarwal RK, Connelly DT, Ray SG, Ball J, Charles RG. Early complications of permanent pacemaker implantation: no difference between dual and single chamber systems. Br. Heart J. 73(6), 571–575 (1995).
   PubMedGoogle Scholar
• Wilkoff BL. How to treat and identify device infections. Heart Rhythm 4(11), 1467–1470 (2007).
   Google Scholar
• Klug D, Balde M, Pavin D et al.; PEOPLE Study Group. Risk factors related to infections of implanted pacemakers and cardioverter–defibrillators: results of a large prospective study. Circulation 116(12), 1349–1355 (2007).
   PubMed Web of Science ®Google Scholar
• Uslan DZ, Sohail MR, St Sauver JL et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch. Intern. Med. 167(7), 669–675 (2007).
   PubMed Web of Science ®Google Scholar
• Poole JE, Gleva MJ, Mela T et al.; REPLACE Registry Investigators. Complication rates associated with pacemaker or implantable cardioverter–defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation 122(16), 1553–1561 (2010).
   PubMed Web of Science ®Google Scholar
• Al-Khatib SM, Lucas FL, Jollis JG, Malenka DJ, Wennberg DE. The relation between patients’ outcomes and the volume of cardioverter–defibrillator implantation procedures performed by physicians treating Medicare beneficiaries. J. Am. Coll. Cardiol. 46(8), 1536–1540 (2005).
   PubMed Web of Science ®Google Scholar
• Cabell CH, Heidenreich PA, Chu VH et al. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990–1999. Am. Heart J. 147(4), 582–586 (2004).
   PubMed Web of Science ®Google Scholar
• Voigt A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J. Am. Coll. Cardiol. 48(3), 590–591 (2006).
   PubMed Web of Science ®Google Scholar
• Uslan DZ, Gleva MJ, Warren DK et al. Cardiovascular implantable electronic device replacement infections and prevention: results from the REPLACE Registry. Pacing Clin. Electrophysiol. 35(1), 81–87 (2012).
   PubMed Web of Science ®Google Scholar
• Baman TS, Gupta SK, Valle JA, Yamada E. Risk factors for mortality in patients with cardiac device-related infection. Circ. Arrhythm. Electrophysiol. 2(2), 129–134 (2009).
   PubMed Web of Science ®Google Scholar
• Sohail MR, Uslan DZ, Khan AH et al. Management and outcome of permanent pacemaker and implantable cardioverter–defibrillator infections. J. Am. Coll. Cardiol. 49(18), 1851–1859 (2007).
   PubMed Web of Science ®Google Scholar
• Bongiorni MG, Tascini C, Tagliaferri E et al. Microbiology of cardiac implantable electronic device infections. Europace 14(9), 1334–1339 (2012).
   PubMed Web of Science ®Google Scholar
• Bloom H, Heeke B, Leon A et al. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin. Electrophysiol. 29(2), 142–145 (2006).
   PubMed Web of Science ®Google Scholar
• Lekkerkerker JC, van Nieuwkoop C, Trines SA et al. Risk factors and time delay associated with cardiac device infections: Leiden device registry. Heart 95(9), 715–720 (2009).
   PubMed Web of Science ®Google Scholar
• Sohail MR, Uslan DZ, Khan AH et al. Risk factor analysis of permanent pacemaker infection. Clin. Infect. Dis. 45(2), 166–173 (2007).
   PubMed Web of Science ®Google Scholar
• Borleffs CJ, Thijssen J, de Bie MK et al. Recurrent implantable cardioverter–defibrillator replacement is associated with an increasing risk of pocket-related complications. Pacing Clin. Electrophysiol. 33(8), 1013–1019 (2010).
   PubMed Web of Science ®Google Scholar
• Nery PB, Fernandes R, Nair GM et al. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences. J. Cardiovasc. Electrophysiol. 21(7), 786–790 (2010).
   PubMed Web of Science ®Google Scholar
• Trappe HJ, Pfitzner P, Klein H, Wenzlaff P. Infections after cardioverter–defibrillator implantation: observations in 335 patients over 10 years. Br. Heart J. 73(1), 20–24 (1995).
   PubMedGoogle Scholar
• Chamis AL, Peterson GE, Cabell CH et al. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter–defibrillators. Circulation 104(9), 1029–1033 (2001).
   PubMed Web of Science ®Google Scholar
• Uslan DZ, Sohail MR, Friedman PA et al. Frequency of permanent pacemaker or implantable cardioverter–defibrillator infection in patients with Gram-negative bacteremia. Clin. Infect. Dis. 43(6), 731–736 (2006).
   PubMed Web of Science ®Google Scholar
• Le KY, Sohail MR, Friedman PA et al.; Mayo Cardiovascular Infections Study Group. Clinical predictors of cardiovascular implantable electronic device-related infective endocarditis. Pacing Clin. Electrophysiol. 34(4), 450–459 (2011).
   PubMed Web of Science ®Google Scholar
• Golzio PG, Fanelli AL, Vinci M et al. Lead vegetations in patients with local and systemic cardiac device infections: prevalence, risk factors, and therapeutic effects. Europace 15(1), 89–100 (2013).
   PubMed Web of Science ®Google Scholar
• Dalal A, Asirvatham SJ, Chandrasekaran K, Seward JB, Tajik AJ. Intracardiac echocardiography in the detection of pacemaker lead endocarditis. J. Am. Soc. Echocardiogr. 15(9), 1027–1028 (2002).
   PubMed Web of Science ®Google Scholar
• Bongiorni MG, Di Cori A, Soldati E et al. Intracardiac echocardiography in patients with pacing and defibrillating leads: a feasibility study. Echocardiography 25(6), 632–638 (2008).
   PubMed Web of Science ®Google Scholar
• Erba PA, Conti U, Lazzeri E et al. Added value of 99mTc-HMPAO-labeled leukocyte SPECT/CT in the characterization and management of patients with infectious endocarditis. J. Nucl. Med. 53(8), 1235–1243 (2012).
   PubMed Web of Science ®Google Scholar
• Sarrazin JF, Philippon F, Tessier M et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. J. Am. Coll. Cardiol. 59(18), 1616–1625 (2012).
   PubMed Web of Science ®Google Scholar
• Athan E, Chu VH, Tattevin P et al.; ICE-PCS Investigators. Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. JAMA 307(16), 1727–1735 (2012).
   PubMed Web of Science ®Google Scholar
• Chua JD, Wilkoff BL, Lee I, Juratli N, Longworth DL, Gordon SM. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann. Intern. Med. 133(8), 604–608 (2000).
   PubMed Web of Science ®Google Scholar
• Cacoub P, Leprince P, Nataf P et al. Pacemaker infective endocarditis. Am. J. Cardiol. 82(4), 480–484 (1998).
   PubMed Web of Science ®Google Scholar
• Grammes JA, Schulze CM, Al-Bataineh M et al. Percutaneous pacemaker and implantable cardioverter–defibrillator lead extraction in 100 patients with intracardiac vegetations defined by transesophageal echocardiogram. J. Am. Coll. Cardiol. 55(9), 886–894 (2010).
   PubMed Web of Science ®Google Scholar
• Pérez Baztarrica G, Gariglio L, Salvaggio F et al. Transvenous extraction of pacemaker leads in infective endocarditis with vegetations =20 mm: our experience. Clin. Cardiol. 35(4), 244–249 (2012).
   PubMed Web of Science ®Google Scholar
• Ferguson TB Jr, Ferguson CL, Crites K, Crimmins-Reda P. The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations. J. Thorac. Cardiovasc. Surg. 111(4), 742–751; discussion 751 (1996).
   PubMedGoogle Scholar
• Sohail MR, Henrikson CA, Braid-Forbes MJ, Forbes KF, Lerner DJ. Mortality and cost associated with cardiovascular implantable electronic device infections. Arch. Intern. Med. 171(20), 1821–1828 (2011).
   PubMedGoogle Scholar
• Klug D, Lacroix D, Savoye C et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation 95(8), 2098–2107 (1997).
   PubMed Web of Science ®Google Scholar
• Le KY, Sohail MR, Friedman PA et al.; Mayo Cardiovascular Infections Study Group. Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm 8(11), 1678–1685 (2011).
   PubMed Web of Science ®Google Scholar
• de Bie MK, van Rees JB, Thijssen J et al. Cardiac device infections are associated with a significant mortality risk. Heart Rhythm 9(4), 494–498 (2012).
   PubMed Web of Science ®Google Scholar
• Deharo JC, Quatre A, Mancini J et al. Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study. Heart 98(9), 724–731 (2012).
   PubMed Web of Science ®Google Scholar